Nuveen Asset Management, LLC Supernus Pharmaceuticals, Inc. Call Options Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SUPN
# of Institutions
260Shares Held
57.3MCall Options Held
84.1KPut Options Held
61.2K-
Black Rock Inc. New York, NY10.4MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$161 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.57MShares$92.9 Million1.66% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$69.4 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$66.5 Million0.02% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.39B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...